Overview

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Status:
Completed

Trial end date:
2018-05-22

Target enrollment:

Participant gender:

Summary

This study aims to assess the effects of early basal insulin therapy in previously non-diabetic de novo kidney transplant patients in reducing the incidence of new onset diabetes in particular and abnormal glucose metabolism in general during subsequent follow-up.The ITP NODAT study should be seen in connection with the Vienna SAPT-NODAT study (clinicaltrials.gov record number: NCT01680185), as for the final analysis, the data yielded from the three arms in those two studies will be used for an pooled analysis.

Phase:

Phase 3

Details

Lead Sponsor:

Medical University of Vienna

Collaborators:

Charite University, Berlin, Germany
Hospital del Mar
Medical University of Graz

Treatments:

Insulin
Insulin Lispro
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human